Panel Discussion: Evaluating Different Combination Strategies to Develop More Effective Cancer Treatments for Curing the Patients in Need
Time: 2:30 pm
day: Day Two
Details:
- Which of the current state of the art immunotherapies are likely to combine well with neoantigen therapies?
- Beyond checkpoint inhibitors, what combinations seem the most promising?
- Are there certain combinations which work better for different stages of cancer?
- Discussing combining neoantigen therapies with PD-L1 therapies, chemotherapies and immunoglobins.
